The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study

Background: To describe trends and clinical experiences in applying commercial pharmacogenetic testing among pediatric patients with neuropsychiatric disorders. Methods: Demographic and clinical data of patients receiving GeneSight(®) testing from January 2015 to November 2016 at an urban pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ariefdjohan, Merlin, Lee, Yee Ming, Stutzman, Danielle L., LeNoue, Sean, Wamboldt, Marianne Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396342/
https://www.ncbi.nlm.nih.gov/pubmed/34449718
http://dx.doi.org/10.3390/pediatric13030049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396342/
https://www.ncbi.nlm.nih.gov/pubmed/34449718
http://dx.doi.org/10.3390/pediatric13030049

Ejemplares similares